Tapewire

NYSE · USD

EW

Edwards Lifesciences Corp

Export transactions ↓
Tapewire entity
3026
SEC CIK
0001099800
Parsed reports
947

Last 12 months

Inside the activity.

0 purchase rows · 54 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202503
Dec 2025010
Jan 202603
Feb 202603
Mar 202604
Apr 202605
May 2026012
Jun 202602
Jul 202604
Aug 202606
Sep 202601
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
July 09, 2019 Filed Jul 10, 2019 21:02 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
Exercise / conversionCommon Stock 32,850 $35.79 $1,175,537.25
Disclosure

SEC source: 0001225208-19-010178 · doc4.xml · nonDerivative · entry 1

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 105,769.82

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 26, 2019.

Read SEC document
July 05, 2019 Filed Jul 8, 2019 18:25 UTC
WANG HUIMINCVP, Japan & Intercontinental
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 4,650 $0.00 Strike: $35.79 $0.00
Disclosure

SEC source: 0001225208-19-010100 · doc4.xml · derivative · entry 3

WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,550

Underlying: Common Stock · 4,650 shares

Expires 2020-05-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 05, 2019 Filed Jul 8, 2019 18:25 UTC
WANG HUIMINCVP, Japan & Intercontinental
SaleCommon Stock 4,650 $186.17 $865,690.50
Disclosure

SEC source: 0001225208-19-010100 · doc4.xml · nonDerivative · entry 2

WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,248.1286

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 21, 2019.

Read SEC document
July 05, 2019 Filed Jul 8, 2019 18:25 UTC
WANG HUIMINCVP, Japan & Intercontinental
Exercise / conversionCommon Stock 4,650 $35.79 $166,400.25
Disclosure

SEC source: 0001225208-19-010100 · doc4.xml · nonDerivative · entry 1

WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,898.1286

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 21, 2019.

Read SEC document
July 01, 2019 Filed Jul 1, 2019 22:12 UTC
Wood Larry LCVP, TAVR
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 6,716 $0.00 Strike: $41.94 $0.00
Disclosure

SEC source: 0001225208-19-009690 · doc4.xml · derivative · entry 4

Wood Larry L · CIK 0001440660 · CVP, TAVR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,588

Underlying: Common Stock · 6,716 shares

Expires 2021-05-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2018.

Read SEC document
July 01, 2019 Filed Jul 1, 2019 22:12 UTC
Wood Larry LCVP, TAVR
SaleCommon Stock 6,716 $186.95 $1,255,532.69
Disclosure

SEC source: 0001225208-19-009690 · doc4.xml · nonDerivative · entry 2

Wood Larry L · CIK 0001440660 · CVP, TAVR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,428.6071

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2018.

F2 · price: This transaction was executed in multiple trades at prices ranging from $186.68 to $187.02. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
July 01, 2019 Filed Jul 1, 2019 22:12 UTC
Wood Larry LCVP, TAVR
Exercise / conversionCommon Stock 6,716 $41.94 $281,669.04
Disclosure

SEC source: 0001225208-19-009690 · doc4.xml · nonDerivative · entry 1

Wood Larry L · CIK 0001440660 · CVP, TAVR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 124,144.6071

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2018.

Read SEC document
June 14, 2019 Filed Jun 14, 2019 22:00 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 5,369 $0.00 Strike: $35.79 $0.00
Disclosure

SEC source: 0001225208-19-009277 · doc4.xml · derivative · entry 6

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,062

Underlying: Common Stock · 5,369 shares

Expires 2020-05-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 21, 2019.

Read SEC document
June 14, 2019 Filed Jun 14, 2019 22:00 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
SaleCommon Stock 5,369 $184.55 $990,848.95
Disclosure

SEC source: 0001225208-19-009277 · doc4.xml · nonDerivative · entry 2

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,674.3275

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 21, 2019.

Read SEC document
June 14, 2019 Filed Jun 14, 2019 22:00 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
Exercise / conversionCommon Stock 5,369 $35.79 $192,129.67
Disclosure

SEC source: 0001225208-19-009277 · doc4.xml · nonDerivative · entry 1

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,043.3275

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 21, 2019.

Read SEC document
June 14, 2019 Filed Jun 14, 2019 22:00 UTC
Szyman Catherine M.CVP, Critical Care
SaleCommon Stock 328 $184.55 $60,532.40
Disclosure

SEC source: 0001225208-19-009276 · doc4.xml · nonDerivative · entry 3

Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 990

F2 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person's spouse on August 29, 2018.

Read SEC document
June 14, 2019 Filed Jun 14, 2019 22:00 UTC
Szyman Catherine M.CVP, Critical Care
SaleCommon Stock 774 $184.55 $142,841.70
Disclosure

SEC source: 0001225208-19-009276 · doc4.xml · nonDerivative · entry 2

Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,475.5729

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 29, 2018.

Read SEC document
June 14, 2019 Filed Jun 14, 2019 22:00 UTC
Szyman Catherine M.CVP, Critical Care
SaleCommon Stock 372 $184.55 $68,652.60
Disclosure

SEC source: 0001225208-19-009276 · doc4.xml · nonDerivative · entry 1

Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,249.5729

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 29, 2018.

Read SEC document
June 12, 2019 Filed Jun 13, 2019 00:45 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 32,850 $0.00 Strike: $35.79 $0.00
Disclosure

SEC source: 0001225208-19-009189 · doc4.xml · derivative · entry 8

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 361,350

Underlying: Common Stock · 32,850 shares

Expires 2020-05-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 12, 2019 Filed Jun 13, 2019 00:45 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
SaleCommon Stock 11,629 $184.65 $2,147,244.85
Disclosure

SEC source: 0001225208-19-009189 · doc4.xml · nonDerivative · entry 5

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,919.82

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 26, 2019.

F5 · price: This transaction was executed in multiple trades at prices ranging from $184.3600 to $185.3000. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
June 12, 2019 Filed Jun 13, 2019 00:45 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
SaleCommon Stock 8,321 $183.82 $1,529,591.18
Disclosure

SEC source: 0001225208-19-009189 · doc4.xml · nonDerivative · entry 4

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,548.82

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 26, 2019.

F4 · price: This transaction was executed in multiple trades at prices ranging from $183.3600 to $184.3500. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
June 12, 2019 Filed Jun 13, 2019 00:45 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
SaleCommon Stock 1,900 $182.85 $347,423.36
Disclosure

SEC source: 0001225208-19-009189 · doc4.xml · nonDerivative · entry 3

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,869.82

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 26, 2019.

F3 · price: This transaction was executed in multiple trades at prices ranging from $182.3200 to $183.3000. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
June 12, 2019 Filed Jun 13, 2019 00:45 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
SaleCommon Stock 1,000 $186.41 $186,410.10
Disclosure

SEC source: 0001225208-19-009189 · doc4.xml · nonDerivative · entry 2

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,769.82

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 26, 2019.

F2 · price: This transaction was executed in multiple trades at prices ranging from $185.6900 to $186.6700. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
June 12, 2019 Filed Jun 13, 2019 00:45 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
Exercise / conversionCommon Stock 32,850 $35.79 $1,175,537.25
Disclosure

SEC source: 0001225208-19-009189 · doc4.xml · nonDerivative · entry 1

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,769.82

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 26, 2019.

Read SEC document
June 05, 2019 Filed Jun 5, 2019 21:59 UTC
WANG HUIMINCVP, Japan & Intercontinental
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 4,650 $0.00 Strike: $35.79 $0.00
Disclosure

SEC source: 0001225208-19-008902 · doc4.xml · derivative · entry 3

WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,200

Underlying: Common Stock · 4,650 shares

Expires 2020-05-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 21, 2019.

Read SEC document
June 05, 2019 Filed Jun 5, 2019 21:59 UTC
WANG HUIMINCVP, Japan & Intercontinental
SaleCommon Stock 4,650 $175.50 $816,075.00
Disclosure

SEC source: 0001225208-19-008902 · doc4.xml · nonDerivative · entry 2

WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,173.1557

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 21, 2019.

Read SEC document
June 05, 2019 Filed Jun 5, 2019 21:59 UTC
WANG HUIMINCVP, Japan & Intercontinental
Exercise / conversionCommon Stock 4,650 $35.79 $166,400.25
Disclosure

SEC source: 0001225208-19-008902 · doc4.xml · nonDerivative · entry 1

WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,823.1557

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 21, 2019.

Read SEC document
June 03, 2019 Filed Jun 3, 2019 20:51 UTC
Wood Larry LCVP, TAVR
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 6,716 $0.00 Strike: $41.94 $0.00
Disclosure

SEC source: 0001225208-19-008725 · doc4.xml · derivative · entry 4

Wood Larry L · CIK 0001440660 · CVP, TAVR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,304

Underlying: Common Stock · 6,716 shares

Expires 2021-05-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2018.

Read SEC document
June 03, 2019 Filed Jun 3, 2019 20:51 UTC
Wood Larry LCVP, TAVR
SaleCommon Stock 6,716 $169.75 $1,140,041.00
Disclosure

SEC source: 0001225208-19-008725 · doc4.xml · nonDerivative · entry 2

Wood Larry L · CIK 0001440660 · CVP, TAVR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,385.9386

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2018.

Read SEC document
June 03, 2019 Filed Jun 3, 2019 20:51 UTC
Wood Larry LCVP, TAVR
Exercise / conversionCommon Stock 6,716 $41.94 $281,669.04
Disclosure

SEC source: 0001225208-19-008725 · doc4.xml · nonDerivative · entry 1

Wood Larry L · CIK 0001440660 · CVP, TAVR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 124,101.9386

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2018.

Read SEC document
May 30, 2019 Filed May 30, 2019 22:14 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
SaleCommon Stock 3,000 $169.60 $508,789.80
Disclosure

SEC source: 0001225208-19-008644 · doc4.xml · nonDerivative · entry 1

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 43,832

F1 · price: This transaction was executed in multiple trades at prices ranging from $169.17 to $170.08. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
May 17, 2019 Filed May 17, 2019 21:58 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 5,369 $0.00 Strike: $35.79 $0.00
Disclosure

SEC source: 0001225208-19-008185 · doc4.xml · derivative · entry 6

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,431

Underlying: Common Stock · 5,369 shares

Expires 2020-05-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 21, 2019.

Read SEC document
May 17, 2019 Filed May 17, 2019 21:58 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
SaleCommon Stock 5,369 $175.06 $939,897.14
Disclosure

SEC source: 0001225208-19-008185 · doc4.xml · nonDerivative · entry 2

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,674.3275

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 21, 2019.

Read SEC document
May 17, 2019 Filed May 17, 2019 21:58 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
Exercise / conversionCommon Stock 5,369 $35.79 $192,129.67
Disclosure

SEC source: 0001225208-19-008185 · doc4.xml · nonDerivative · entry 1

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,043.3275

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 21, 2019.

Read SEC document
May 15, 2019 Filed May 15, 2019 22:57 UTC
Szyman Catherine M.CVP, Critical Care
SaleCommon Stock 328 $177.92 $58,357.76
Disclosure

SEC source: 0001225208-19-008079 · doc4.xml · nonDerivative · entry 3

Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care

10b5-1 filing: Not disclosed

Ownership: Indirect · By Spouse

Disclosed balance after: 1,318

F2 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person's spouse on August 29, 2018.

Read SEC document
May 15, 2019 Filed May 15, 2019 22:57 UTC
Szyman Catherine M.CVP, Critical Care
SaleCommon Stock 774 $177.92 $137,710.08
Disclosure

SEC source: 0001225208-19-008079 · doc4.xml · nonDerivative · entry 2

Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,621.5729

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 29, 2018.

Read SEC document
May 15, 2019 Filed May 15, 2019 22:57 UTC
Szyman Catherine M.CVP, Critical Care
SaleCommon Stock 372 $177.92 $66,186.24
Disclosure

SEC source: 0001225208-19-008079 · doc4.xml · nonDerivative · entry 1

Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,395.5729

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 29, 2018.

Read SEC document
May 14, 2019 Filed May 14, 2019 23:36 UTC
Ullem Scott B.CVP, Chief Financial Officer
Tax withholdingCommon Stock 1,104 $178.17 $196,699.68
Disclosure

SEC source: 0001225208-19-007998 · doc4.xml · nonDerivative · entry 4

Ullem Scott B. · CIK 0001446989 · CVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,564

Read SEC document
May 14, 2019 Filed May 15, 2019 00:23 UTC
Wood Larry LCVP, TAVR
Tax withholdingCommon Stock 1,066 $178.17 $189,929.22
Disclosure

SEC source: 0001225208-19-008003 · doc4.xml · nonDerivative · entry 4

Wood Larry L · CIK 0001440660 · CVP, TAVR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,385.9386

Read SEC document
May 14, 2019 Filed May 15, 2019 00:21 UTC
Szyman Catherine M.CVP, Critical Care
Tax withholdingCommon Stock 1,066 $178.17 $189,929.22
Disclosure

SEC source: 0001225208-19-008002 · doc4.xml · nonDerivative · entry 4

Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,767.5729

Read SEC document
May 14, 2019 Filed May 15, 2019 00:02 UTC
WANG HUIMINCVP, Japan & Intercontinental
Tax withholdingCommon Stock 570 $178.17 $101,556.90
Disclosure

SEC source: 0001225208-19-008001 · doc4.xml · nonDerivative · entry 4

WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,173.1557

Read SEC document
May 14, 2019 Filed May 14, 2019 23:04 UTC
SELLERS ROBERT W.A.VP, Corporate Controller
Tax withholdingCommon Stock 143 $178.17 $25,478.31
Disclosure

SEC source: 0001225208-19-007995 · doc4.xml · nonDerivative · entry 2

SELLERS ROBERT W.A. · CIK 0001600739 · VP, Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,446.9846

Read SEC document
May 14, 2019 Filed May 14, 2019 23:00 UTC
Lemercier Jean-Luc MCVP, EMEA, Canada, Latin Amer
Tax withholdingCommon Stock 36 $178.17 $6,414.12
Disclosure

SEC source: 0001225208-19-007994 · doc4.xml · nonDerivative · entry 2

Lemercier Jean-Luc M · CIK 0001710625 · CVP, EMEA, Canada, Latin Amer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,651.8535

Read SEC document
May 14, 2019 Filed May 14, 2019 22:39 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
Tax withholdingCommon Stock 1,078 $178.17 $192,067.26
Disclosure

SEC source: 0001225208-19-007992 · doc4.xml · nonDerivative · entry 4

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,674.3275

Read SEC document
May 12, 2019 Filed May 14, 2019 23:36 UTC
Ullem Scott B.CVP, Chief Financial Officer
Exercise / conversionPerformance Rights · Derivative 2,784 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-007998 · doc4.xml · derivative · entry 6

Ullem Scott B. · CIK 0001446989 · CVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,784 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: On May 12, 2016, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 7, 2019, the Compensation Committee of the Board of Directors determined that 75.77% of the target shares would vest as of May 12, 2019, and the actual number of shares vested are reflected on this Form and the balance of the award terminated.

F1 · derivative.exercise_date: On May 12, 2016, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 7, 2019, the Compensation Committee of the Board of Directors determined that 75.77% of the target shares would vest as of May 12, 2019, and the actual number of shares vested are reflected on this Form and the balance of the award terminated.

F1 · derivative.expiration_date: On May 12, 2016, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 7, 2019, the Compensation Committee of the Board of Directors determined that 75.77% of the target shares would vest as of May 12, 2019, and the actual number of shares vested are reflected on this Form and the balance of the award terminated.

F1 · derivative.underlying_shares: On May 12, 2016, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 7, 2019, the Compensation Committee of the Board of Directors determined that 75.77% of the target shares would vest as of May 12, 2019, and the actual number of shares vested are reflected on this Form and the balance of the award terminated.

Read SEC document
May 12, 2019 Filed May 14, 2019 23:36 UTC
Ullem Scott B.CVP, Chief Financial Officer
Tax withholdingCommon Stock 1,236 $181.10 $223,839.60
Disclosure

SEC source: 0001225208-19-007998 · doc4.xml · nonDerivative · entry 3

Ullem Scott B. · CIK 0001446989 · CVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,668

F1 · shares: On May 12, 2016, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 7, 2019, the Compensation Committee of the Board of Directors determined that 75.77% of the target shares would vest as of May 12, 2019, and the actual number of shares vested are reflected on this Form and the balance of the award terminated.

Read SEC document
May 12, 2019 Filed May 14, 2019 23:36 UTC
Ullem Scott B.CVP, Chief Financial Officer
Tax withholdingCommon Stock 506 $181.10 $91,636.60
Disclosure

SEC source: 0001225208-19-007998 · doc4.xml · nonDerivative · entry 2

Ullem Scott B. · CIK 0001446989 · CVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,904

Read SEC document
May 12, 2019 Filed May 14, 2019 23:36 UTC
Ullem Scott B.CVP, Chief Financial Officer
Exercise / conversionCommon Stock 2,784 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-007998 · doc4.xml · nonDerivative · entry 1

Ullem Scott B. · CIK 0001446989 · CVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,410

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On May 12, 2016, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 7, 2019, the Compensation Committee of the Board of Directors determined that 75.77% of the target shares would vest as of May 12, 2019, and the actual number of shares vested are reflected on this Form and the balance of the award terminated.

F1 · price: On May 12, 2016, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 7, 2019, the Compensation Committee of the Board of Directors determined that 75.77% of the target shares would vest as of May 12, 2019, and the actual number of shares vested are reflected on this Form and the balance of the award terminated.

Read SEC document
May 12, 2019 Filed May 14, 2019 22:24 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
Exercise / conversionPerformance Rights · Derivative 11,119 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-007989 · doc4.xml · derivative · entry 4

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 11,119 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: On May 12, 2016, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 7, 2019, the Compensation Committee of the Board of Directors determined that 75.77% of the target shares would vest as of May 12, 2019, and the actual number of shares vested are reflected on this Form and the balance of the award terminated.

F1 · shares: On May 12, 2016, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 7, 2019, the Compensation Committee of the Board of Directors determined that 75.77% of the target shares would vest as of May 12, 2019, and the actual number of shares vested are reflected on this Form and the balance of the award terminated.

F1 · price: On May 12, 2016, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 7, 2019, the Compensation Committee of the Board of Directors determined that 75.77% of the target shares would vest as of May 12, 2019, and the actual number of shares vested are reflected on this Form and the balance of the award terminated.

F1 · derivative.exercise_date: On May 12, 2016, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 7, 2019, the Compensation Committee of the Board of Directors determined that 75.77% of the target shares would vest as of May 12, 2019, and the actual number of shares vested are reflected on this Form and the balance of the award terminated.

F1 · derivative.expiration_date: On May 12, 2016, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 7, 2019, the Compensation Committee of the Board of Directors determined that 75.77% of the target shares would vest as of May 12, 2019, and the actual number of shares vested are reflected on this Form and the balance of the award terminated.

Read SEC document
May 12, 2019 Filed May 14, 2019 22:24 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
Exercise / conversionCommon Stock 11,119 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-007989 · doc4.xml · nonDerivative · entry 1

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,919.82

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On May 12, 2016, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 7, 2019, the Compensation Committee of the Board of Directors determined that 75.77% of the target shares would vest as of May 12, 2019, and the actual number of shares vested are reflected on this Form and the balance of the award terminated.

F1 · price: On May 12, 2016, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 7, 2019, the Compensation Committee of the Board of Directors determined that 75.77% of the target shares would vest as of May 12, 2019, and the actual number of shares vested are reflected on this Form and the balance of the award terminated.

Read SEC document
May 12, 2019 Filed May 15, 2019 00:23 UTC
Wood Larry LCVP, TAVR
Exercise / conversionPerformance Rights · Derivative 2,689 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-008003 · doc4.xml · derivative · entry 6

Wood Larry L · CIK 0001440660 · CVP, TAVR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,689 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: On May 12, 2016, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 7, 2019, the Compensation Committee of the Board of Directors determined that 75.77% of the target shares would vest as of May 12, 2019, and the actual number of shares vested are reflected on this Form and the balance of the award terminated.

F1 · derivative.exercise_date: On May 12, 2016, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 7, 2019, the Compensation Committee of the Board of Directors determined that 75.77% of the target shares would vest as of May 12, 2019, and the actual number of shares vested are reflected on this Form and the balance of the award terminated.

F1 · derivative.expiration_date: On May 12, 2016, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 7, 2019, the Compensation Committee of the Board of Directors determined that 75.77% of the target shares would vest as of May 12, 2019, and the actual number of shares vested are reflected on this Form and the balance of the award terminated.

F1 · derivative.underlying_shares: On May 12, 2016, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 7, 2019, the Compensation Committee of the Board of Directors determined that 75.77% of the target shares would vest as of May 12, 2019, and the actual number of shares vested are reflected on this Form and the balance of the award terminated.

Read SEC document
May 12, 2019 Filed May 15, 2019 00:23 UTC
Wood Larry LCVP, TAVR
Tax withholdingCommon Stock 1,334 $181.10 $241,587.40
Disclosure

SEC source: 0001225208-19-008003 · doc4.xml · nonDerivative · entry 3

Wood Larry L · CIK 0001440660 · CVP, TAVR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 118,451.9386

F1 · shares: On May 12, 2016, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 7, 2019, the Compensation Committee of the Board of Directors determined that 75.77% of the target shares would vest as of May 12, 2019, and the actual number of shares vested are reflected on this Form and the balance of the award terminated.

Read SEC document
May 12, 2019 Filed May 15, 2019 00:23 UTC
Wood Larry LCVP, TAVR
Tax withholdingCommon Stock 707 $181.10 $128,037.70
Disclosure

SEC source: 0001225208-19-008003 · doc4.xml · nonDerivative · entry 2

Wood Larry L · CIK 0001440660 · CVP, TAVR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 119,785.9386

Read SEC document
May 12, 2019 Filed May 15, 2019 00:23 UTC
Wood Larry LCVP, TAVR
Exercise / conversionCommon Stock 2,689 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-008003 · doc4.xml · nonDerivative · entry 1

Wood Larry L · CIK 0001440660 · CVP, TAVR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,492.9386

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On May 12, 2016, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 7, 2019, the Compensation Committee of the Board of Directors determined that 75.77% of the target shares would vest as of May 12, 2019, and the actual number of shares vested are reflected on this Form and the balance of the award terminated.

F1 · price: On May 12, 2016, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 7, 2019, the Compensation Committee of the Board of Directors determined that 75.77% of the target shares would vest as of May 12, 2019, and the actual number of shares vested are reflected on this Form and the balance of the award terminated.

Read SEC document
May 12, 2019 Filed May 15, 2019 00:21 UTC
Szyman Catherine M.CVP, Critical Care
Exercise / conversionPerformance Rights · Derivative 2,595 $0.00 $0.00
Disclosure

SEC source: 0001225208-19-008002 · doc4.xml · derivative · entry 6

Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,595 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: On May 12, 2016, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 7, 2019, the Compensation Committee of the Board of Directors determined that 75.77% of the target shares would vest as of May 12, 2019, and the actual number of shares vested are reflected on this Form and the balance of the award terminated.

F1 · derivative.exercise_date: On May 12, 2016, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 7, 2019, the Compensation Committee of the Board of Directors determined that 75.77% of the target shares would vest as of May 12, 2019, and the actual number of shares vested are reflected on this Form and the balance of the award terminated.

F1 · derivative.expiration_date: On May 12, 2016, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 7, 2019, the Compensation Committee of the Board of Directors determined that 75.77% of the target shares would vest as of May 12, 2019, and the actual number of shares vested are reflected on this Form and the balance of the award terminated.

F1 · derivative.underlying_shares: On May 12, 2016, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 7, 2019, the Compensation Committee of the Board of Directors determined that 75.77% of the target shares would vest as of May 12, 2019, and the actual number of shares vested are reflected on this Form and the balance of the award terminated.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.